Scheriproct

Scheriproct is a rectal medication combining Cinchocaine Hydrochloride and Prednisolone Caproate. It is used for local relief of pain and inflammation in the rectal area. This product is manufactured by Karo Healthcare AB in the EU.

Scheriproct is typically used for the relief of pain and inflammation in the rectal area. The combination of Cinchocaine Hydrochloride and Prednisolone Caproate works to provide local anesthetic and anti-inflammatory effects. This medication is often recommended for conditions that cause discomfort in the rectal region.

Common effects of Scheriproct may include temporary relief of pain and reduction of inflammation in the rectal area. Some users might experience mild side effects such as local irritation or itching. These effects are generally short-lived and subside as the medication's effects wear off.

Scheriproct should be used as directed by a healthcare professional. It is important to follow the recommended dosage and administration instructions. Avoid prolonged use without medical supervision. If symptoms persist or worsen, consult a healthcare provider.

Scheriproct may interact with other medications, especially those that affect the rectal area. It is advisable to inform your healthcare provider about all medications you are taking. Avoid using other rectal products simultaneously unless directed by a healthcare professional.